Clinical Research

Dr. Fagien is a sought-after researcher, and he continuously performs clinical trials for the world’s top pharmaceutical companies. If you would like to receive information about upcoming trials, please call 561.393.9898 or email us.

Clinical Study Experience

2003 to Present

Protocol Title Protocol Date Status
Long-term safety and Patient
Satisfaction of Effectiveness of
Facial Aesthetic Treatment with
BOTOX: A 10-Year International
Experience
June 2012 Completed
Bimatoprost in the Treatment of
Eyelash Hypotrichosis
November 2012 Completed
A One Year, Multicenter, Double-
Masked,Randomized, Parallel-Group
Study Assessing the Safety and
Efficacy of Once Daily Application
of Bimatoprost 0.03% Solution
Compared to Vehicle to Treat
Hypotrichosis of the Eyelashes
from Varied Etiologies
Phase – III
September 2009 Completed
Assessing Immediate Changes in the
Appearance of Fine Lines/Wrinkles
After Use of a Clarisonic Opal and
Pro RT Serum
May 2010 Completed
A Multicenter Double-Blind
Randomized, Placebo-controlled,
Parallel-group Extension Study to
Evaluate the Safety and Efficacy of
BOTOX (Botulinum Toxin Type A)
Purified Neurotoxin Complex in
Subjects with Facial Rhytides
(Crow’s Feet Lines and Glabellar Lines)
June 2011 Completed
A non-interventional observational
and medical records review of patient
outcomes with bimatoprost ophthalmic
solution 0.03% (Latisse) for the treatment
of hypotrichosis of the eyelashes
May 2010 Completed
A Prospective Open Label,
Randomized, Crossover Study
Evaluating BOTOX Cosmetic or
VISTABEL for Injection and
JUVEDERM Injectable Gel for the
Treatment of Moderate to Severe
Facial Wrinkles and Folds
December 2010 Completed
A Multicenter, Double-Blind,
Randomized, Placebo-Controlled,
Parallel-Group Study to Evaluate the
Safety and Efficacy of BOTOX
(Botulinum Toxin Type A) Purified
Neurotoxin Complex in Subjects with
Facial Rhytides (Crow’s Feet Lines
and Glabellar Lines)
November 2010 Completed
A Phase III, Randomized, Placebo-
Controlled,Double-Blind Study of the
Safety and Duration of Efficacy of
Reloxin in Correction of Moderate
to Severe Glabellar Lines
Phase – III
June 2006 Completed
A Placebo Controlled Study to
Assess Patient-Reported Outcomes
In Subject Receiving Botox
(Botulinum Toxin Type A) for the
Treatment of Moderate to Severe
Glabellar Rhytids
January 2005 Completed
A Randomized Study of the Safety
and Effectiveness of DL6049
(Poly-L-Latic Acid) versus
CosmoPlast Collagen Implant in the
Treatment of Nasolabial Fold Wrinkles
November 2003 Completed
A Multicenter, Double-Masked,
Randomized, Parallel Study
Assessing the Safety and Efficacy of
Once-Daily Application of
Bimatoprost Solution Compared to
Vehicle in Increasing Overall
Eyelash Prominence
March 2007 Completed
A Phase 3, Multicenter, Open-Label,
Extension Study to Assess the Long-
Term Safety of Repeat Administration
of Reloxin in the Treatment of
Glabellar Lines
Phase – III

Contact Us

Contact Us

Meet Dr. Fagien

Steven Fagien, MD is one of the world’s foremost experts in oculoplastic surgery, and he has devoted more than 25 years to facial aesthetics.

Learn more...